Literature DB >> 26261633

Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.

Jianbo Zhu1, Lan Yang1, Weiyan You2, Xiaobin Cui1, Yunzhao Chen1, Jianming Hu1, Wei Liu1, Shugang Li3, Xiaoyue Song1, Yutao Wei2, Wenjie Zhang1, Feng Li1.   

Abstract

MicroRNAs (miRNAs) are a family of small noncoding RNAs that act as oncogenes and tumor suppressors. Single nucleotide polymorphisms (SNPs) in miRNAs may be associated with changes in phenotype and function. The aim of this study was to verify whether genetic variations in candidate microRNA (miRNA or miR) genes could contribute to esophageal squamous cell carcinoma (ESCC) susceptibility. A case-control study in 248 Kazakh patients with ESCC and 300 frequency matched control subjects was carried out to examine the potential association of six miRNA (miR-100 rs1834306, miR-34b/c rs4938723, miR-375 rs6715345, miR-146a rs2910164, miR-423 rs6505162 and miR-373 rs12983273) polymorphisms with risk of ESCC. We found that miR-100 rs1834306 T>C polymorphism was associated with a significant decreased risk of ESCC. In the recessive model, when the miR-100 rs1834306 TT/TC genotypes were used as the reference group, the CC homozygote genotype was associated with a significant decreased risk for ESCC (adjusted OR=0.495, 95% CI: 0.349-0.702, P=8.05×10(-5)). In the dominant model, when the miR-100 rs1834306 TT genotypes was used as the reference group, the TC/CC genotype were associated with a borderline statistically decreased risk for ESCC (adjusted OR=0.665, 95% CI: 0.430-1.031, P=0.067). In addition, the miR-100 rs1834306 C allele in the Kazakh population was significantly associated with decreased risk of ESCC (OR=0.609, 95% CI: 0.48-0.78, P=8.37×10(-5)). These findings indicated that functional polymorphism miR-100 rs1834306 C>T might contribute to decreased ESCC risk.

Entities:  

Keywords:  Kazakh; esophageal squamous cell carcinoma; miRNA; risk; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 26261633      PMCID: PMC4525967     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

Review 1.  Genetic polymorphisms and esophageal cancer risk.

Authors:  Toru Hiyama; Masaharu Yoshihara; Shinji Tanaka; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

2.  Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.

Authors:  V Boni; R Zarate; J C Villa; E Bandrés; M A Gomez; E Maiello; J Garcia-Foncillas; E Aranda
Journal:  Pharmacogenomics J       Date:  2010-06-29       Impact factor: 3.550

3.  Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women.

Authors:  Tair Kontorovich; Asaf Levy; Michael Korostishevsky; Uri Nir; Eitan Friedman
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

4.  Trends in morbidity and mortality for oesophageal cancer in Linxian County, 1959-1983.

Authors:  J B Lu; W X Yang; J M Liu; Y S Li; Y M Qin
Journal:  Int J Cancer       Date:  1985-12-15       Impact factor: 7.396

5.  Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus.

Authors:  M C Yu; D H Garabrant; J M Peters; T M Mack
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

Review 6.  MiRNAs and cancer.

Authors:  Rosa Visone; Carlo M Croce
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

7.  Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population.

Authors:  Xiao-Bin Cui; Yun-Zhao Chen; Xue-Lian Pang; Wei Liu; Jian-Ming Hu; Shu-Gang Li; Lan Yang; Wen-Jie Zhang; Chun-Xia Liu; Yu-Wen Cao; Jin-Fang Jiang; Wen-Yi Gu; James Pang; Lei Yang; Xiang-Lin Yuan; Shi-Ying Yu; Feng Li
Journal:  Gene       Date:  2013-08-24       Impact factor: 3.688

8.  Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.

Authors:  Wei Xu; Jijun Xu; Shifeng Liu; Bo Chen; Xueli Wang; Yan Li; Yun Qian; Weihong Zhao; Jianqing Wu
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

9.  A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression.

Authors:  Qian Xu; Qiguan Dong; Caiyun He; Wenjing Liu; Liping Sun; Jingwei Liu; Chengzhong Xing; Xiaohang Li; Bengang Wang; Yuan Yuan
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 10.  Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

Authors:  Yaping Xu; Xinmin Yu; Qixun Chen; Weimin Mao
Journal:  World J Surg Oncol       Date:  2012-08-25       Impact factor: 2.754

View more
  14 in total

1.  MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.

Authors:  Dimitra-Ioanna Lampropoulou; Gerasimos Aravantinos; Konstantinos Laschos; Theodosis Theodosopoulos; Christos Papadimitriou; Maria Gazouli
Journal:  Int J Colorectal Dis       Date:  2019-10-09       Impact factor: 2.571

2.  Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease.

Authors:  Abdullah Hamadi; Rashid Mir; Ali Mahzari; Abdulrahim Hakami; Reema Almotairi; Gasim Dobie; Fawaz Hamdi; Mohammed Hassan Nahari; Razan Alhefzi; Mohammed Alasseiri; Nora Y Hakami; Hadeel Al Sadoun; Osama M Al-Amer; Jameel Barnawi; Hassan A Madkhali
Journal:  Curr Issues Mol Biol       Date:  2022-06-01       Impact factor: 2.976

3.  Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.

Authors:  Sara Sanaei; Mohammad Hashemi; Maryam Rezaei; Seyed Mehdi Hashemi; Gholamreza Bahari; Saeid Ghavami
Journal:  Biomed Rep       Date:  2016-05-23

Review 4.  The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis.

Authors:  Ru Chen; Yonglan Zheng; Lin Zhuo; Shengfeng Wang
Journal:  Oncotarget       Date:  2017-06-20

5.  Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer.

Authors:  Hong Zhang; Yafei Zhang; Xixi Zhao; Xingcong Ma; Wanjun Yan; Wen Wang; Zitong Zhao; Qian Yang; Xi Sun; Hui Luan; Xiaoyan Gao; Shuqun Zhang
Journal:  Oncotarget       Date:  2017-07-18

6.  An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.

Authors:  Hua Li; Shuling Diao; Jingsen Li; Baoxin Ma; Shuanghu Yuan
Journal:  Oncotarget       Date:  2017-04-25

Review 7.  Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior.

Authors:  Francisca Dias; Mariana Morais; Ana Luísa Teixeira; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2018-10-12       Impact factor: 6.639

8.  miR-146a C/G polymorphism increased the risk of head and neck cancer, but overall cancer risk: an analysis of 89 studies.

Authors:  Dezhong Sun; Xiaoyan Zhang; Xiaolei Zhang
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

9.  The association between polymorphisms in microRNA genes and cervical cancer in a Chinese Han population.

Authors:  Li Chuanyin; Wang Xiaona; Yan Zhiling; Zhang Yu; Liu Shuyuan; Yang Jie; Hong Chao; Shi Li; Yang Hongying; Yao Yufeng
Journal:  Oncotarget       Date:  2017-09-23

10.  Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.

Authors:  Bin Xu; Ya Zhu; Yu Tang; Zhenyong Zhang; Qiaxian Wen
Journal:  Med Sci Monit       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.